Inicio › Cáncer de próstata › Carolina del Norte
Ensayos clínicos de Cáncer de próstata en Carolina del Norte
47 estudios sobre Cáncer de próstata buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
- Durham32 estudios
- Charlotte7 estudios
- Winston-Salem5 estudios
- Concord5 estudios
- New Bern3 estudios
- Asheville3 estudios
Texto oficial del estudio (inglés)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT06931340Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- y 6 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Margaret R Pardee Memorial Hospital, Hendersonville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Atrium Health Levine Cancer Institute, Charlotte
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 28 sept 2026 · NCT06095089DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Duke University Medical Center, Durham
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT06800313This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Duke Cancer Center Cary, Cary
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07028853High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Durham VA Medical Center, Durham, NC, Durham
- Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Durham VA Medical Center, Durham, NC, Durham
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT04038502Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Duke University Medical Center, Durham
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT07493512Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Associated Urologists of North Carolina (AUNC), Raleigh
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 14 sept 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Duke University Medical Center, Durham
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Durham VA Medical Center, Durham
- CarolinaEast Medical Center, New Bern
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Urology Specialists of the Carolinas - University Place, Charlotte
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07723248The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Duke University, Durham
ReclutandoEstudio observacional
Edades de 18 en adelante · Hombres · Actualizado el 27 ago 2026 · NCT07050433Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Levine Cancer Institute, Charlotte
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 24 ago 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Duke University Medical Center, Durham
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 21 ago 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Duke University medical center, Durham
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 20 ago 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- ECU Health Oncology Kinston, Kinston
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 ago 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Duke University Medical Center - Duke Cancer Center, Durham
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 ago 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05919264A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 10 ago 2026 · NCT06067841A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06751329Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
- Duke University, Durham
ReclutandoEstudio observacional
Edades de 40 en adelante · Hombres · Actualizado el 6 ago 2026 · NCT07144228Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health University City/LCI-University, Charlotte
- Levine Cancer Institute-Ballantyne, Charlotte
- y 9 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Wake Forest University Health Sciences, Winston-Salem
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT05691465A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Duke Cancer Center, Durham
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Levine Cancer Institute, Charlotte
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Duke University, Durham
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 25 jun 2026 · NCT06457919Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT07463833Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- W.G. Bill Hefner Medical Center, Salisbury
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 15 jun 2026 · NCT05422911Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Duke University Medical Center, Durham
ReclutandoFase 4
Edades de 18 a 100 · Hombres · Actualizado el 4 jun 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- y 1 más
ReclutandoEstudio observacional
Edades de 21 en adelante · Hombres · Actualizado el 22 may 2026 · NCT03151629Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
- W.G. Bill Hefner VA Medical Center, Salisbury
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 13 abr 2026 · NCT04337580Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Durham VA Medical Center, Durham, NC, Durham
ReclutandoFase 2/3
Edades de 18 en adelante · Hombres · Actualizado el 8 abr 2026 · NCT04787744De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.